TNFRSF14 alterations reduce HVEM expression, enhancing the alloantigen-presenting capacity of lymphoma B cells and increasing the risk of acute graft-versus-host disease in allogeneic stem cell transplantation 38. The gene discussed is TNFRSF14; the disease is lymphoma.